These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 28270301)

  • 1. Synapses in neurodegenerative diseases.
    Bae JR; Kim SH
    BMB Rep; 2017 May; 50(5):237-246. PubMed ID: 28270301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders.
    Radulović S; Sunkara S; Maurer C; Leitinger G
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy at synapses in neurodegenerative diseases.
    Lee W; Kim SH
    Arch Pharm Res; 2019 May; 42(5):407-415. PubMed ID: 30937842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitophagy in neurodegenerative diseases.
    Rodolfo C; Campello S; Cecconi F
    Neurochem Int; 2018 Jul; 117():156-166. PubMed ID: 28797885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic vesicle trafficking and Parkinson's disease.
    Esposito G; Ana Clara F; Verstreken P
    Dev Neurobiol; 2012 Jan; 72(1):134-44. PubMed ID: 21563316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria and neurodegeneration.
    Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
    Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of connexins in neurodegenerative diseases (Review).
    Xing J; Xu C
    Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deconstruction for reconstruction: the role of proteolysis in neural plasticity and disease.
    Bingol B; Sheng M
    Neuron; 2011 Jan; 69(1):22-32. PubMed ID: 21220096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting stress granules in neurodegenerative diseases: A focus on biological function and dynamics disorders.
    Fang M; Liu Y; Huang C; Fan S
    Biofactors; 2024; 50(3):422-438. PubMed ID: 37966813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
    Mattson MP
    Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-gp transporter and its role in neurodegenerative diseases.
    Rapposelli S; Digiacomo M; Balsamo A
    Curr Top Med Chem; 2009; 9(2):209-17. PubMed ID: 19200006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Roles of cyclin-dependent kinase 5 in central nervous system development and neurodegenerative diseases].
    Chen J; Wang ZF
    Sheng Li Xue Bao; 2010 Aug; 62(4):295-308. PubMed ID: 20717630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of α-synuclein in neurotransmission and synaptic plasticity.
    Cheng F; Vivacqua G; Yu S
    J Chem Neuroanat; 2011 Dec; 42(4):242-8. PubMed ID: 21167933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal autophagy and neurodegenerative diseases.
    Son JH; Shim JH; Kim KH; Ha JY; Han JY
    Exp Mol Med; 2012 Feb; 44(2):89-98. PubMed ID: 22257884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer's disease.
    Hroudová J; Singh N; Fišar Z
    Biomed Res Int; 2014; 2014():175062. PubMed ID: 24900954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
    Tenreiro S; Munder MC; Alberti S; Outeiro TF
    J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders.
    Olesen MA; Villavicencio-Tejo F; Quintanilla RA
    Transl Neurodegener; 2022 Jul; 11(1):36. PubMed ID: 35787292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
    Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
    Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders.
    Villavicencio-Tejo F; Olesen MA; Navarro L; Calisto N; Iribarren C; García K; Corsini G; Quintanilla RA
    Neurotox Res; 2023 Dec; 42(1):4. PubMed ID: 38103074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.